Magenta Lifecare informs about revised statement of deviation or variation of funds
Pursuant to Regulation 32 of the SEBI Listing Regulations and SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019, Magenta Lifecare has informed that there are no deviation(s) or variation(s) in respect of the utilization of the proceeds of the Initial Public Offer (IPO) of the Company during the Half Year and Year ended on 31st March, 2025. A statement confirming that there is no deviation or variation in the utilization of these proceeds is enclosed. This is for information and records.
The above information is a part of company’s filings submitted to BSE.
